David A. Siegel Twist Bioscience Corp Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q4 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Twist Bioscience Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 215,600 shares of TWST stock, worth $8.99 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

215,600

Previous 280,500 23.14%

Holding current value

$8.99 Million

Previous $12.7 Million 20.94%

% of portfolio

0.02%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$36.89 - $52.7 $2.39 Million - $3.42 Million	-64,900 Reduced 23.14%	215,600 $10 Million
Q3 2024 Nov 14, 2024	SELL	$36.72 - $58.88 $2.18 Million - $3.5 Million	-59,500 Reduced 17.5%	280,500 $12.7 Million
Q2 2024 Aug 14, 2024	BUY	$27.95 - $53.0 $7.06 Million - $13.4 Million	252,700 Added 289.46%	340,000 $16.8 Million
Q1 2024 May 15, 2024	SELL	$32.28 - $41.5 $187,224 - $240,700	-5,800 Reduced 6.23%	87,300 $3 Million
Q4 2023 Feb 14, 2024	BUY	$15.08 - $38.61 $446,368 - $1.14 Million	29,600 Added 46.61%	93,100 $3.43 Million
Q3 2023 Nov 14, 2023	SELL	$18.62 - $26.57 $249,508 - $356,038	-13,400 Reduced 17.43%	63,500 $1.29 Million
Q2 2023 Aug 14, 2023	SELL	$11.49 - $20.46 $405,597 - $722,238	-35,300 Reduced 31.46%	76,900 $1.57 Million
Q1 2023 May 15, 2023	BUY	$14.6 - $30.9 $1.41 Million - $2.98 Million	96,500 Added 614.65%	112,200 $1.69 Million
Q4 2022 Feb 14, 2023	BUY	$21.92 - $39.37 $149,056 - $267,716	6,800 Added 76.4%	15,700 $373,000
Q3 2022 Nov 14, 2022	SELL	$33.44 - $56.56 $127,071 - $214,928	-3,800 Reduced 29.92%	8,900 $314,000
Q2 2022 Aug 15, 2022	SELL	$26.2 - $54.0 $461,120 - $950,400	-17,600 Reduced 58.09%	12,700 $444,000
Q1 2022 May 16, 2022	BUY	$38.58 - $83.27 $1.17 Million - $2.52 Million	30,300 New	30,300 $1.5 Million
Q4 2021 Feb 14, 2022	SELL	$75.47 - $135.88 $324,521 - $584,284	-4,300 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$95.64 - $131.48 $1.12 Million - $1.54 Million	-11,700 Reduced 73.13%	4,300 $460,000
Q2 2021 Aug 16, 2021	SELL	$88.13 - $142.06 $2.72 Million - $4.39 Million	-30,900 Reduced 65.88%	16,000 $2.13 Million
Q1 2021 May 17, 2021	BUY	$105.48 - $207.97 $3.23 Million - $6.36 Million	30,600 Added 187.73%	46,900 $5.81 Million
Q4 2020 Feb 16, 2021	BUY	$76.64 - $167.89 $758,736 - $1.66 Million	9,900 Added 154.69%	16,300 $2.3 Million
Q2 2020 Aug 14, 2020	SELL	$26.4 - $45.3 $184,800 - $317,100	-7,000 Reduced 52.24%	6,400 $290,000
Q1 2020 May 15, 2020	BUY	$19.71 - $35.15 $264,114 - $471,010	13,400 New	13,400 $410,000
Q3 2019 Nov 14, 2019	SELL	$23.72 - $33.99 $398,496 - $571,032	-16,800 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$21.74 - $33.2 $365,232 - $557,760	16,800 New	16,800 $487,000

Others Institutions Holding TWST

# of Institutions

270

Shares Held

67.2M

Call Options Held

118K

Put Options Held

40.2K

View Full List

About Twist Bioscience Corp

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.35B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

More about TWST

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account